CVC Explores Options for €11 Billion Drugmaker Recordati bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
(Bloomberg) CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA, according to people familiar with the matter.Most Read from BloombergRay Dalio’s Famous Trade Is Sputtering, Investors BailingTesla Stock in ‘No Man’s Land’ After 43% Rout Ahead of EarningsBillionaire Pinaults Fight to Pull Gucci Off the Discount Rack‘Mag Seven’ Jump Minutes Away From Tesla’s Results: Markets WrapTaylor Swift Is Proof That How We Critique Music Is BrokenThe buyo
CVC Said to Explore Options for €11 Billion Drugmaker Recordati bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.
On Thursday, Recordati Spa s board of directors reviewed and approved preliminary consolidated results for fiscal year 2023, which closed with a net income of EUR389.2 million, up 25 percent from.
Akkadian Partners wishes to inform the market that it has retained all the shares it has acquired in recent months and did not participate in the sale of shares that triggered the sharpest fall in the SRD market at the close of trading on Monday 3.